Sanacora G, Yan Z, Popoli M. The stressed synapse 2.0: Pathophysiological mechanisms in stress-related neuropsychiatric disorders. Nat Rev Neurosci. 2022;23:86–103.
Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis. 2018;8:S3–8.
PubMed PubMed Central Google Scholar
Group GBDNDC. Global, regional, and national burden of neurological disorders during 1990-2015: A systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017;16:877–97.
McCarron RM, Shapiro B, Rawles J, Luo J. Depression. Ann Intern Med. 2021;174:ITC65–ITC80.
Yang HS. Human genetics clarifies the relationship between depression and Alzheimer’s disease. Biol Psychiatry. 2022;92:2–4.
Zhang C, Wang L, Xu Y, Huang Y, Huang J, Zhu J, et al. Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer’s disease and depression. Eur J Med Chem. 2022;236:114347.
Cummings J, Feldman HH, Scheltens P. The “rights” of precision drug development for Alzheimer’s disease. Alzheimers Res Ther. 2019;11:76.
PubMed PubMed Central Google Scholar
Yang S, Zhu G. 7,8-dihydroxyflavone and neuropsychiatric disorders: A translational perspective from the mechanism to drug development. Curr Neuropharmacol. 2022;20:1479–97.
Jiang B, Xiong Z, Yang J, Wang W, Wang Y, Hu ZL, et al. Antidepressant-like effects of ginsenoside rg1 are due to activation of the bdnf signalling pathway and neurogenesis in the hippocampus. Br J Pharmacol. 2012;166:1872–87.
PubMed PubMed Central CAS Google Scholar
Yi YS. New mechanisms of ginseng saponin-mediated anti-inflammatory action via targeting canonical inflammasome signaling pathways. J Ethnopharmacol. 2021;278:114292.
Ai PH, Chen S, Liu XD, Zhu XN, Pan YB, Feng DF, et al. Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice. Transl Neurodegener. 2020;9:18.
PubMed PubMed Central CAS Google Scholar
Kawakami I, Iga JI, Takahashi S, Lin YT, Fujishiro H. Towards an understanding of the pathological basis of senile depression and incident dementia: Implications for treatment. Psychiatry Clin Neurosci. 2022. https://doi.org/10.1111/pcn.13485
Article PubMed PubMed Central Google Scholar
Juszczyk G, Mikulska J, Kasperek K, Pietrzak D, Mrozek W, Herbet M. Chronic stress and oxidative stress as common factors of the pathogenesis of depression and alzheimer’s disease: The role of antioxidants in prevention and treatment. Antioxidants (Basel). 2021;10:1439.
Linnemann C, Lang UE. Pathways connecting late-life depression and dementia. Front Pharmacol. 2020;11:279.
PubMed PubMed Central CAS Google Scholar
Li C, Sui C, Wang W, Yan J, Deng N, Du X, et al. Baicalin attenuates oxygen-glucose deprivation/reoxygenation-induced injury by modulating the BDNF-TRKB/PI3K/AKT and MAPK/ERK1/2 signaling axes in neuron-astrocyte cocultures. Front Pharmacol. 2021;12:599543.
PubMed PubMed Central CAS Google Scholar
Wang ZH, Xiang J, Liu X, Yu SP, Manfredsson FP, Sandoval IM, et al. Deficiency in BDNF/TrkB neurotrophic activity stimulates delta-secretase by upregulating C/EBPbeta in Alzheimer’s disease. Cell Rep. 2019;28:655–69.e5.
PubMed PubMed Central CAS Google Scholar
Lim JY, Reighard CP, Crowther DC. The pro-domains of neurotrophins, including BDNF, are linked to Alzheimer’s disease through a toxic synergy with abeta. Hum Mol Genet. 2015;24:3929–38.
PubMed PubMed Central CAS Google Scholar
Guan W, Xu DW, Ji CH, Wang CN, Liu Y, Tang WQ, et al. Hippocampal miR-206-3p participates in the pathogenesis of depression via regulating the expression of BDNF. Pharmacol Res. 2021;174:105932.
Fani G, Mannini B, Vecchi G, Cascella R, Cecchi C, Dobson CM, et al. Abeta oligomers dysregulate calcium homeostasis by mechanosensitive activation of AMPA and NMDA receptors. ACS Chem Neurosci. 2021;12:766–81.
Miyamoto T, Stein L, Thomas R, Djukic B, Taneja P, Knox J, et al. Phosphorylation of tau at Y18, but not tau-fyn binding, is required for Tau to modulate nmda receptor-dependent excitotoxicity in primary neuronal culture. Mol Neurodegener. 2017;12:41.
PubMed PubMed Central Google Scholar
Song Z, Bian Z, Zhang Z, Wang X, Zhu A, Zhu G. Astrocytic kir4.1 regulates nmdar/calpain signaling axis in lipopolysaccharide-induced depression-like behaviors in mice. Toxicol Appl Pharmacol. 2021;429:115711.
Arimon M, Takeda S, Post KL, Svirsky S, Hyman BT, Berezovska O. Oxidative stress and lipid peroxidation are upstream of amyloid pathology. Neurobiol Dis. 2015;84:109–19.
PubMed PubMed Central CAS Google Scholar
Pena-Bautista C, Tirle T, Lopez-Nogueroles M, Vento M, Baquero M, Chafer-Pericas C. Oxidative damage of DNA as early marker of Alzheimer’s disease. Int J Mol Sci. 2019;20:6136.
PubMed Central CAS Google Scholar
Mahmoud AM, Alexander MY, Tutar Y, Wilkinson FL, Venditti A. Oxidative stress in metabolic disorders and drug-induced injury: The potential role of Nrf2 and PPARs activators. Oxid Med Cell Longev. 2017;2017:2508909.
PubMed PubMed Central Google Scholar
Song L, Wu X, Wang J, Guan Y, Zhang Y, Gong M, et al. Antidepressant effect of catalpol on corticosterone-induced depressive-like behavior involves the inhibition of HPA axis hyperactivity, central inflammation and oxidative damage probably via dual regulation of NF-kappab and Nrf2. Brain Res Bull. 2021;177:81–91.
Diniz BS, Mendes-Silva AP, Silva LB, Bertola L, Vieira MC, Ferreira JD, et al. Oxidative stress markers imbalance in late-life depression. J Psychiatr Res. 2018;102:29–33.
Shen F, Song Z, Xie P, Li L, Wang B, Peng D, et al. Polygonatum sibiricum polysaccharide prevents depression-like behaviors by reducing oxidative stress, inflammation, and cellular and synaptic damage. J Ethnopharmacol. 2021;275:114164.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer’s disease. Lancet. 2021;397:1577–90.
PubMed PubMed Central CAS Google Scholar
Wang X, Gao F, Xu W, Cao Y, Wang J, Zhu G. Depichering the effects of Astragaloside IV on AD-like phenotypes: A systematic and experimental investigation. Oxid Med Cell Longev. 2021;2021:1020614.
PubMed PubMed Central Google Scholar
Min W, Liu C, Yang Y, Sun X, Zhang B, Xu L, et al. Alterations in hypothalamic-pituitary-adrenal/thyroid (HPA/HPT) axes correlated with the clinical manifestations of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39:206–11.
Song Z, Shen F, Zhang Z, Wu S, Zhu G. Calpain inhibition ameliorates depression-like behaviors by reducing inflammation and promoting synaptic protein expression in the hippocampus. Neuropharmacology. 2020;174:108175.
Mahar I, Bambico FR, Mechawar N, Nobrega JNStress. serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev. 2014;38:173–92.
Kim Y, Cho SH. The effect of ginsenosides on depression in preclinical studies: A systematic review and meta-analysis. J Ginseng Res. 2021;45:420–32.
O’Connor DB, Thayer JF, Vedhara K. Stress and health: A review of psychobiological processes. Annu Rev Psychol. 2021;72:663–88.
Dwyer JB, Aftab A, Radhakrishnan R, Widge A, Rodriguez CI, Carpenter LL, et al. Hormonal treatments for major depressive disorder: State of the art. Am J Psychiatry. 2020;177:686–705.
PubMed PubMed Central Google Scholar
Mou Z, Huang Q, Chu SF, Zhang MJ, Hu JF, Chen NH, et al. Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis. Biomed Pharmacother. 2017;92:962–71.
Zheng X, Liang Y, Kang A, Ma SJ, Xing L, Zhou YY, et al. Peripheral immunomodulation with ginsenoside Rg1 ameliorates neuroinflammation-induced behavioral deficits in rats. Neuroscience. 2014;256:210–22.
Wang YT, Wang XL, Feng ST, Chen NH, Wang ZZ, Zhang Y. Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression. Pharmacol Res. 2021;171:105761.
Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: New insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238–49.
PubMed PubMed Central CAS Google Scholar
Fan C, Song Q, Wang P, Li Y, Yang M, Yu SY. Neuroprotective effects of ginsenoside-Rg1 against depression-like behaviors via suppressing glial activation, synaptic deficits, and neuronal apoptosis in rats. Front Immunol. 2018;9:2889.
PubMed PubMed Central CAS Google Scholar
Liu Z, Qi Y, Cheng Z, Zhu X, Fan C, Yu SY. The effects of ginsenoside Rg1 on chronic stress induced depression-like behaviors, BDNF expression and the phosphorylation of PKA and CREB in rats. Neuroscience. 2016;322:358–69.
Zhu X, Gao R, Liu Z, Cheng Z, Qi Y, Fan C, et al. Ginsenoside Rg1 reverses stress-induced depression-like behaviours and brain-derived neurotrophic factor expression within the prefrontal cortex. Eur J Neurosci. 2016;44:1878–85.
Wang J, Shen F, Zhang Z, Zhu G. Effects of ginsenoside Rg1 on depression-like behaviors, expression of hippocampal synaptic proteins and activation of glial cells in stressed mice. J Biol. 2021;38:26–30.
留言 (0)